Guangdong Jiaying Pharmaceutical (002198.SZ) main shareholder Orient completes reduction of 1% shareholding.

Announcement from Guangdong Jiaying Pharmaceutical(002198.SZ): Shareholder Orient, holding more than 5% of the company's shares, has cumulatively reduced its stake by 5.075 million shares, accounting for 1.00% of the total share capital. The reduction plan has been successfully completed.